Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Mineral And Bone Disorder Treatment Market In 2029?

In recent times, there has been robust growth in the size of the market for treatment of mineral and bone disorders. It’s projected that the market will escalate from $3.3 billion in 2024 to $3.54 billion in 2025, experiencing a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the previous period include chronic kidney disease, an aging population, heightened awareness about mineral and bone disorders, rising accessibility to treatments for mineral and bone disorders, and increased disposable income levels.

The market for treatment of bone and mineral disorders is anticipated to experience substantial growth in the forthcoming years. It’s projected to reach a value of$4.69 billion by 2029″ with a CAGR of 7.3%. The predicted expansion during the forecast period is largely due to increased interest in quality of life treatments, personalized medicine’s escalating demand, generous government healthcare expenditure, and heightened consciousness about the significance of early diagnosis. Key trends during the projection period encompass progress in medical research, advancements in pharmaceuticals, digital healthcare, biologic treatments, and the rise of telehealth and remote patient monitoring.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12956&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Mineral And Bone Disorder Treatment Market?

An upsurge in the elderly population is forecasted to stimulate the expansion of the mineral and bone disorder treatment market in the future. The elderly are characterized as individuals aged 65 or above. This group typically experiences a decrease in muscle and bone mass, resulting in diminished strength and frailty. Treatments targeting mineral and bone disorders have the potential to curb the effects of aging on muscles, bones, and joints, fortify bones and slow down the rate of bone degeneration. To illustrate, in July 2024, the UK Parliament’s House of Commons Library, a government entity in the UK, predicted that in 2022, there will be 12.7 million individuals, or 19% of the total population, aged 65 or above in the UK. This number is anticipated to escalate to 22.1 million, constituting 27% of the population, by 2072. Consequently, the growing elderly population is fuelling the expansion of the mineral and bone disorder treatment market.

Which Key Market Segments Comprise the Mineral And Bone Disorder Treatment Market and Drive Its Revenue Growth?

The mineral and bone disorder treatmentmarket covered in this report is segmented –

1) By Treatment: Diet; Nutrition; Medication; Supplements; Dialysis

2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Diet: Calcium-Rich Foods; Vitamin D-Enriched Foods; Phosphorus-Rich Foods

2) By Nutrition: Nutritional Counseling; Fortified Food Products; Meal Replacement Programs

3) By Medication: Bisphosphonates; Hormonal Therapies; RANK Ligand Inhibitors

4) By Supplements: Calcium Supplements; Vitamin D Supplements; Multivitamin Supplements

5) By Dialysis: Hemodialysis; Peritoneal Dialysis; Continuous Renal Replacement Therapy (CRRT)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12956&type=smp

Which Areas Are Leading Regions in the Mineral And Bone Disorder Treatment Market Expansion Across the Globe?

North America was the largest region in the mineral and bone disorder treatment market in 2024. The regions covered in mineral and bone disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Strategic Trends Steering theMineral And Bone Disorder Treatment Market Direction?

Leading firms in the mineral and bone disorder treatment market are concentrating on product innovation and securing approval for these new treatments as a strategy to solidify their market dominance. The approval for mineral and bone drugs has seen an upswing, attributable to an aging population and the increased incidence of chronic kidney ailments such as TYMLOS (abaloparatide), a medication with the active ingredient of abaloparatide, a lab-created variant of the human parathyroid hormone. For example, in December 2022, US-based biopharmaceutical corporation, Radius Health Inc., was granted approval for TYMLOS (abaloparatide), a parathyroid hormone-related peptide analogue [PTHrP(1-34)]. It is used to heighten bone density in men suffering from osteoporosis and at high risk of fracture. The drug functions as an anabolic agent for the bone, selectively triggering the parathyroid hormone 1 receptor (PTH1R) found in osteoblasts and osteocytes, thereby boosting bone formation and density.

View the full report here:

https://www.thebusinessresearchcompany.com/report/mineral-and-bone-disorder-treatment-global-market-report

How Is the Mineral And Bone Disorder Treatment Market Conceptually Defined?

Mineral and bone disorder treatment refers to a treatment procedure recommended when there is an imbalance in the levels of calcium and phosphorus in the blood. The treatment regulates the levels of certain minerals and hormones in the blood to prevent bone and blood vessel damage.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12956

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model